Local breast surgeon Cary Kaufman, M.D. recently presented at two prestigious medical conferences, on a groundbreaking innovation that improves the treatment of breast cancer.
ProstateCancer911.com: Redesigned For Men Struggling to Choose the Right Treatment for Prostate Cancer, from World …
World-Renowned Robotic Prostate Cancer Surgeon, Dr. David Samadi, Creates Most Comprehensive Online Resource for Prostate Cancer Prevention, Diagnosis, Treatment and Recovery — ProstateCancer911.com (PRWeb April 14, 2015) Read the full story at http://www.prweb.com/releases/2015/04/prweb12651457.htm
FAYETTEVILLE, AR — A Northwest Arkansas surgeon is the first in the country to pioneer the use of what's being called 'groundbreaking innovation' in breast cancer treatment. Dr. Michael Cross, North Hills Surgery Center and Highlands Oncology Group are now offering patients a new device that can help improve the treatment of breast cancer.
A new study represents the first time low temperature plasmas (LTPs) have been applied on cells grown directly from patient tissue samples. Taking both healthy prostate cells and prostate cancer tissue cells from a single patient, the study allowed for direct comparison of the effectiveness of the treatment
Cancer Treatment Centers of America® at Western Regional Medical Center Hosts Its First Ever Cancer Treatments …
Cancer Treatment Centers of America® at Western Regional Medical Center is hosting its first ever Annual New Treatments in Oncology conference, focused on advances in cancer research, new treatments and patient care.
Cancer Treatment Centers of America at Midwestern Regional Medical Center to Participate in AccuBoost Accelerated Dose …
CHICAGO, April 1, 2015 /PRNewswire/ — Patients who undergo breast conservation therapy have an even stronger defense to prevent disease recurrence and rid the body of cancer cells following a lumpectomy with the use of AccuBoost®. Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) has been invited by Rhode Island Hospital to participate in a new …
Orphan Drug Approval May Mean New Treatment Option for Mesothelioma, According to Surviving Mesothelioma
A company that produces a cancer vaccine called CRS-207 has been granted orphan drug status for the treatment of malignant mesothelioma, potentially opening new treatment possibilities for patients with this rare cancer.
Aduro Biotech, Inc.
Joan Lunden Breast Cancer Battle Update: 'The Farther I Get from My Chemotherapy, the Better I Feel'
The former Good Morning America host has completed her treatment for triple negative breast cancer